Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. We are a multidisciplinary team formed from neuroscience research groups. We involve scientists in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
Shareholders
2 Public Institutions 7 Venture Capital Firms
The 13 Founders from Polyclinic and University of Milan are neurosurgeons, neurologists, bioengineers, neuropsychologists, biotechnologist, neurophysiology technicians.
Newsroom
Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform
13/02/2025
Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System
05/02/2025
ASST Gaetano Pini
Nuove prospettive di cura per le persone con Parkinson grazie a una ricerca internazionale finanziata dalla Michael J. Fox Foundation for Parkinson’s Research
23/01/2025
NEWRONIKA SECURES INITIAL €2 MILLION IN BLENDED FINANCE FROM EIC ACCELERATOR FOR GROUNDBREAKING PARKINSON'S DISEASE RESEARCH
22/01/2024
EUROPEAN INNOVATION COUNCIL
NEWRONIKA SECURES 2.5 MILLION EUROS GRANT FROM EIC ACCELERATOR The amounts will be used to fund European pivotal clinical trial in adaptive deep brain stimulation to improve the lives of Parkinson’s disease patients
09/03/2023
NEURAL IMPLANT PODCAST
Lothar Krinke on adaptive Deep Brain Stimulation at Newronika
10/12/2022
LIFE SCIENCE INTELLIGENCE
Lothar Krinke, Newronika - Studio Interview | LSI Europe ‘22 - CEO, Lothar Krinke and Newronika are developing AlphaDBS, a closed-loop deep brain neuromodulation system for the management of symptoms due to Parkinson's disease.
SEPT 22, 2022
LIFE SCIENCE INTELLIGENCE
Lothar Krinke, Newronika - Neuromodulation System for Parkinson's | LSI Europe '22
21/09/2022
Lothar Krinke named CEO of Newronika starting the next phase of adaptive Neuromodulation product development.
25/05/2022
Round d’investimento da 8,4 milioni per Newronika
Sept 27, 2019
PR NEWSWIRE
Newronika Raises an 8.4M EUR Series-A Round
26/09/2019
Medtech, la startup italiana Newronika chiude un round da 8,4 milioni
26/09/2019
Eight-hours adaptive deep brain stimulation in patients with Parkinson disease
13/03/2018
1.7 million for startup that fights Parkinson's
14/06/2016
Neuromodulation Therapy Developer Newronika Raises €1.7M in Venture Capital
14/06/2016
Innogest, Intesa Sanpaolo and F3F invest 1.7 million in Newronika
14/06/2016
Newronika chiude un round di venture capital
14/06/2016
È italiano il primo pacemaker intelligente per il Parkinson
02/12/2011
Innogest and Intesa invest 1.7M in Newronika (Deep Brain Stimulation)
14/06/2016
Intesa Sanpaolo: Atlante Ventures co-invest in Newronika
14/06/2016
È italiano il primo pacemaker intelligente per il Parkinson
02/12/2011
Board of Directors
Lorenzo Rossi
CEO
Claudio Giuliano
Chairman
Carlo Sanfilippo
Board member
Scientific Board
Alberto Priori
Chair
Guglielmo Foffani
Member
Andrès Lozano
Member
Sara Marceglia
Member
Elena Moro
Member
Jens Volkmann
Member
Team
Chiara Giuditta Motta
Accounting
Marketing & Sales
Costanza Conti
Clinical Affairs Manager
Regulatory and Clinical Investigation
Daniel Senderowicz
Head of ASIC Dev
aDBS Technology Development
Ernesto Della Torre
Production
aDBS Technology Development
Francesca Brambilla
Accounting
Financial Accounting
Filippo Barlassina
Firmware Developer
aDBS Technology Development
Jacopo Cavagnoli
Industrial Designer
Wearable Devices & UX
Luca Cavagnoli
Production
aDBS Technology Development
Martino Sykora
Firmware Manager
aDBS Technology Development
Mattia Arlotti
VP - Engineering and New Product Development
aDBS Technology Development
Melissa Sementilli
Validation Engineer
aDBS Technology Development
Michael Fattore
Chief Financial Officer
Finance & Investor Relations
Mirela Presecan
Marketing & Sales Coordinator
Marketing & Sales
Roberta Ferrucci
Clinical Advisor
Regulatory and Clinical Investigation
Silvia Bracchi
Accounting
Marketing & Sales
Vanessa Aloia
Firmware
aDBS Technology Development
Valentina Cossa
Lead Technician
aDBS Technology Development
Researcher collaborations are welcome!
Collaborations are at the heart of Newronika's ethos. Our Closed-loop system can work in different areas and applications. Together we can shape the future of Healthcare!
